risk of semaglutide Effects on of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials | Cardiovascular Diabetology Semaglutide linked to reduced risk

Exenatide and pancreatitis: an update

That double-blind, placebo-controlled trial featured more than 17,600 adults aged 45 and older who had overweight and obesity who were either given weekly shots of Wegovy or a placebo

The team of Ralf Jockers in collaboration with the team of Dr Amlie Bonnefond from the European Genomic Institute for Diabetes (EGID, Lille, France), the Huazhong University of Science and Technology (Wuhan, China), the Baylor College of Medicine (Houston, USA) and Imperial College Lonodon (UK) performed a large-scale functional genetics analysis of 60 rare GLP1R mutations

The diagnostic capabilities of endocrinologists extend far beyond basic screening

Lancet Diabetes Endocrinol 2018;6:605617 [DOI] [PubMed] [Google Scholar] 36